Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017)
Amarin Corp Plc\Uk (AMRN) posted quarterly Long-Term Deferred Tax of $11.1 million for Q3 2017, down 51.83% year-over-year from $23.0 million in Q3 2016, and little changed quarter-over-quarter from $11.1 million in Q2 2017.
Amarin Corp Plcuk (AMRN) Long-Term Deferred Tax (2010 - 2017) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Long-Term Deferred Tax for 8 consecutive years, with $11.1 million the latest figure, recorded in Q3 2017.
- In Q3 2017, Long-Term Deferred Tax fell 51.83% year-over-year to $11.1 million; the TTM figure through Sep 2017 stood at $11.1 million (down 51.83% YoY), while the FY2016 annual figure was $11.1 million, down 44.23% from the prior year.
- Long-Term Deferred Tax steadied at $11.1 million in Q3 2017 per AMRN's latest filing, from $11.1 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $23.0 million in Q3 2016 and bottomed at $11.1 million in Q4 2016.
- Historically, Long-Term Deferred Tax has averaged $14.1 million across 5 years, with a median of $12.6 million in 2014.
- Annual changes were most pronounced in 2016 — Long-Term Deferred Tax jumped 63.45% — and 2017, when it sank 51.83%.
- Amarin Corp Plc\Uk's Long-Term Deferred Tax stood at $11.9 million in 2013, then climbed by 5.12% to $12.6 million in 2014, then surged by 58.27% to $19.9 million in 2015, then plunged by 44.23% to $11.1 million in 2016, then changed by 0.0% to $11.1 million in 2017.
- Business Quant data shows AMRN's Long-Term Deferred Tax at $11.1 million in Q3 2017, $11.1 million in Q2 2017, and $11.1 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 11.08 Mn |
| Jun 30, 2017 | 11.08 Mn |
| Mar 31, 2017 | 11.08 Mn |
| Dec 31, 2016 | 11.08 Mn |
| Sep 30, 2016 | 23.01 Mn |
| Jun 30, 2016 | 21.72 Mn |
| Mar 31, 2016 | 18.68 Mn |
| Dec 31, 2015 | 19.87 Mn |
| Sep 30, 2015 | 14.14 Mn |
| Jun 30, 2015 | 13.29 Mn |
| Mar 31, 2015 | 12.65 Mn |
| Dec 31, 2014 | 12.56 Mn |
| Sep 30, 2014 | 11.86 Mn |
| Jun 30, 2014 | 11.94 Mn |
| Mar 31, 2014 | 11.97 Mn |
| Dec 31, 2013 | 11.94 Mn |
| Sep 30, 2013 | 14.43 Mn |
| Jun 30, 2013 | 12.88 Mn |
| Mar 31, 2013 | 11.99 Mn |
| Dec 31, 2012 | 8.04 Mn |